Exercise reduces the risk of breast cancer in older women
the ONA take:
A new study published in the journal Cancer Epidemiology, Biomarkers & Prevention found that regular physical activity decreases the risk of developing breast cancer in postmenopausal women.
Researchers followed postmenopausal women in France for an average of eight and a half years. Those women who had performed regular exercise equivalent to four hours of walking or cycling per week were ten percent less likely to be diagnosed with breast cancer compared with those who did not perform regular exercise.
The decrease in risk was not impacted by other factors like body fat, weight, waist circumference, and degree of exercise from five to nine years prior to the study. This risk diminished if exercise was not continued, and therefore, postmenopausal women should be encouraged to continue regular exercise. The study also demonstrated that walking 30 minutes every day, rather than intense exercise, can be very helpful.
Researchers did not understand the exact reason for the decreased risk, but they suggest that these women may have lived a healthier lifestyle compared with those who did not regularly exercise. Nevertheless, including exercise in a postmenopausal woman's lifestyle may improve her health and decrease her risk of developing breast cancer.
Older women may want to start and maintain a regular exercise regimen.
Older women intent on keeping breast cancer at bay may want to start and maintain a regular exercise regimen, a new study shows. The researchers found that regular physical activity cuts the odds of breast cancer in postmenopausal women, but that protection disappears if women stop exercising.
One expert wasn't surprised by the findings. "As a breast surgeon, one of my roles is to discuss prevention strategies for women," said Dr. Alison Estabrook, chief of the division of breast surgery at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals in New York City.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|